ValidityandReliabilityofClinicalExaminationintheDiagnosisofMyofascialPainSyndromeandMyofascialTriggerPointsinUpperQuarterMuscles

Myofascial pain syndrome (MPS) is a common clinical condition characterized by sensory, motor, and autonomic symptoms caused by myofascial trigger points (MTrPs) — hyperirritable spots in skeletal muscle associated with palpable nodules in taut bands. Despite its estimated prevalence of 93% in pain clinic populations, the diagnosis of MPS remains controversial because validated clinical diagnostic criteria are lacking. The field still awaits criteria that can be validated against a gold standard such as needle EMG examination. Previous systematic reviews have concluded that palpation for MTrPs shows only moderate reliability at best, and have called for higher-quality research.

Most importantly, while many studies have examined the reliability of identifying individual MTrP characteristics, few have assessed whether clinical examination can reliably distinguish MPS patients from healthy individuals — a clinically critical distinction. This gap is particularly important because identifying the specific "relevant MTrPs" that contribute to a patient's MPS is essential for proper clinical management.

The researchers conducted a validity and reliability study using a case-control design at a provincial hospital in Toledo, Spain. They recruited 20 patients with MPS and 20 healthy normal control (HNC) subjects. The MPS diagnosis required at least one active MTrP in at least one of 10 designated upper quarter muscles: splenius capitis, sternocleidomastoid, upper trapezius, levator scapulae, infraspinatus, supraspinatus, anterior deltoid, latissimus dorsi, teres major, and pectoralis major. Patients had to have regional pain involving the head, neck, and/or shoulder girdle persisting for at least two weeks, and could not meet criteria for fibromyalgia syndrome.

Two experienced physical therapist examiners evaluated all subjects. The first examiner (an MPS expert) was unblinded and established the reference diagnosis. The second examiner was blinded to diagnosis group and came from another city to ensure proper blinding. Before the study, both examiners underwent training sessions evaluating 7 MPS patients and 7 asymptomatic subjects to reconcile discrepancies.

Each subject completed self-report questionnaires including VAS pain scale, SF-36 Health Survey, and body pain diagrams before each examination.

The blinded examination occurred 3–4 days after the first examination. The blinded examiner assessed all 10 muscles bilaterally using nine examination maneuvers: palpable taut band, spot tenderness, jump sign, pain referral reported by subject, local twitch response, pressure pain threshold (PPT) with algometry, matchstick test, skin rolling test, and painfully restricted passive range of motion. The blinded examiner could not ask about pain history or whether referred pain reproduced familiar pain, so instead estimated whether MTrPs found could be "relevant" for MPS diagnosis.

The primary outcome was agreement between examiners on classifying subjects as MPS or HNC. Secondary outcomes included agreement on presence of MTrPs in each muscle and outcomes of each examination test. Cohen's kappa statistic was used to measure agreement, interpreted as very good (0.81–1.00), good (0.61–0.80), moderate (0.41–0.60), fair (0.21–0.40), or poor (≤0.20). Sensitivity and specificity were calculated using the first examiner as reference standard.

The two examiners achieved perfect agreement on the primary outcome: interexaminer reliability for identifying subjects with MPS was very good (K=1.0, agreement=100%). For identifying specific muscles leading to MPS diagnosis, agreement was also very good (K=0.81, agreement=81%).

Individual muscle reliability varied. The most reliably identified muscles were supraspinatus (K=1.0), sternocleidomastoid (K=0.96 right, 0.93 left), anterior deltoid (K=0.84 right, 1.0 left), levator scapulae (K=0.93 right, 0.84 left), latissimus dorsi (K=0.77 both sides), and infraspinatus (K=0.77 both sides). The lowest reliability was for splenius capitis (K=0.69 right, 0.55 left) and pectoralis major (K=0.64 right, 0.77 left).

For individual examination maneuvers, all but two showed good or very good agreement. The matchstick test (K=0.20) and skin rolling test (K=0.30) showed poor to fair agreement. All other maneuvers — painfully restricted passive range of motion, muscle strength limited by pain, palpable taut band, spot tenderness, jump sign, pain referral, local twitch response, and PPT — showed K values of 0.61 or higher, with most exceeding 0.71. The percentage of agreement between evaluators exceeded 70% for all muscle-maneuver combinations.

Most examination tests showed statistically significant differences between MPS and HNC subjects (P<0.0001 to P=0.0045). Only three tests failed to discriminate: palpable taut band (P=0.09), local twitch response (P=0.214), and matchstick test (P=0.47). The mean PPT was 2.12 kg/cm² in MPS muscles versus 3.83 kg/cm² in HNC muscles — a difference of 1.71 kg/cm² (P<0.0001). In MPS patients with unilateral involvement, the mean difference between healthy and involved sides was 1.43 kg/cm².

Sensitivity and specificity values were high for most examination tests in most muscles, confirming validity. The matchstick test and skin rolling test had poor sensitivity values that could not be calculated in many muscles.

This study provides important evidence that experienced clinicians can reliably and validly diagnose MPS using standardized clinical examination. The perfect agreement (K=1.0) on distinguishing MPS patients from healthy controls challenges earlier systematic reviews that found only moderate reliability for MTrP palpation. The authors suggest that their thorough, systematic approach using 10 diagnostic tests — rather than the smaller combinations used in previous studies — may explain their superior results.

For clinicians, this supports the use of comprehensive clinical examination for MPS diagnosis, particularly in the upper quarter muscles. The most reliable muscles to assess appear to be supraspinatus, sternocleidomastoid, anterior deltoid, levator scapulae, latissimus dorsi, and infraspinatus. The findings also suggest that PPT algometry can validly discriminate MPS from healthy states, with differences around 1.4–1.7 kg/cm² being clinically meaningful.

However, some caution is warranted. The study used an expert unblinded examiner as reference standard rather than a true gold standard like needle EMG. The 3–4 day interval between examinations, while protecting blinding, differs from typical reliability studies. The blinded examiner also acknowledged that pain behavior cues may have influenced some decisions, suggesting that purely objective criteria may not fully explain the excellent agreement.

Future research should validate these clinical criteria against objective gold standards and examine deep muscles not included here.